Limitations on the detection rate of high-risk HPV by hybrid capture 2 methodology in High Grade Intraepithelial (HSIL) or atypical squamous cells-cannot exclude HSIL (ASC-H) cytological lesions with proved CIN2+

Analytical Cellular Pathology

Volumn 2015, Issue , 2015, Pages

  Noël, Jean Christophe ^a   Simon, Philippe ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; AGED; CANCER GRADING; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOLOGY; ISOLATION AND PURIFICATION; LIMIT OF DETECTION; MIDDLE AGED; PAPILLOMAVIRIDAE; PATHOLOGY; PROCEDURES; RISK FACTOR; UTERINE CERVIX DYSPLASIA; VIROLOGY;

ADULT; AGED; ATYPICAL SQUAMOUS CELLS OF THE CERVIX; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; LIMIT OF DETECTION; MIDDLE AGED; NEOPLASM GRADING; PAPILLOMAVIRIDAE; RISK FACTORS;

EID: 84941695724     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.1155/2015/746502     Document Type: Article

References (21)

1. M. Arbyn, A. Haelens, A. Desomer et al. Cervical cancer screening program and Human Papillomavirus (HPV) testing: update on HPV primary screening. KCE Reports 238, Health Technology Assessment (HTA), Belgian Health Care Knowledge (KCE), Brussels, Belgium, 2015
2. A. R. Giuliano, A. G. Nyitray, A. R. Kreimer et al. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirusrelated cancer incidence by gender and anatomic site of infection. International Journal of Cancer, vol. 136, no. 12, pp. 2752-2760, 2015
3. X. Catteau, P. Simon, and J. Nöel. Evaluation of the oncogenic human papillomavirus DNA test with liquid-based cytology in primary cervical cancer screening and the importance of the ASC/SIL ratio: a belgian study. ISRNObstetrics andGynecology, vol. 2014, Article ID 536495, 5 pages, 2014
4. F. Coutlée, S. Ratnam, A. V. Ramanakumar et al. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. Journal of Medical Virology, vol. 83, no. 6, pp. 1034-1041, 2011
5. G. Halec, L. Alemany, B. Lloveras et al. Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer. The Journal of Pathology, vol. 234, no. 4, pp. 441-451, 2014
6. D. C. Rijkaart, J. Berkhof, L. Rozendaal et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. The Lancet Oncology, vol. 13, no. 1, pp. 78-88, 2012
7. M. Leinonen, P. Nieminen, L. Kotaniemi-Talonen et al. Agespecific evaluation of primaryHuman Papillomavirus screening vs conventional cytology in a randomized setting. Journal of the National Cancer Institute, vol. 101, no. 23, pp. 1612-1623, 2009
8. G. Ronco, P. Giorgi-Rossi, F. Carozzi et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. The Lancet Oncology, vol. 11, no. 3, pp. 249-257, 2010
9. J. Cuzick, C. Clavel, K.-U. Petry et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. International Journal of Cancer, vol. 119, no. 5, pp. 1095-1101, 2006
10. P.E.Castle, S. De Sanjose, Y.-L.Quiao, J.L.Belinson, E. Lazcano-Ponce, andW. Kinney. Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine, vol. 30, supplement 5, pp. F117-F122, 2012
11. J. S. Gibson. Nucleic acid-based assays for the detection of high-risk human papillomavirus: a technical review. Cancer Cytopathology, vol. 122, no. 9, pp. 639-645, 2014
12. X. Catteau, M. Vanhaeverbeek, and J.-C. Nöel. Importance of the residual volume of the cytological solution for the reproducibility of the hybrid capture 2 high-risk human papillomavirus DNA test. Acta Cytologica, vol. 56, no. 4, pp. 375-378, 2012
13. J.-C. Nöel, I. Fayt, M. R. Romero Munoz, P. Simon, and C. Engohan-Aloghe. High prevalence of high-risk human papillomavirus infection among women with Trichomonas vaginalis infection on monolayer cytology. Archives of Gynecology and Obstetrics, vol. 282, no. 5, pp. 503-505, 2010
14. F.W. Abdul-Karim, C. N. Powers, J. S. Berek et al. A typical squamous cells. in The Bethesda System for Reporting Cervical Cytology, R. Nayar and D. C. Wilbur, Eds., pp. 103-134, 3rd edition, 2015
15. M. R. Henry, D. K. Russell, R. D. Luff et al. Epithelial cell abnormalities: squamous. in The Bethesda System for Reporting Cervical Cytology, R. Nayar andD. C. Wilbur, Eds., pp. 135-192, 3rd edition, 2015
16. M. Stoler, C. Bergeron, T. J. Colgan et al. Squamous cell tumours and precursors. in WHO Classification of Tumours of Female Reproductive Organs, R. J. Kurman, M. L. Carcangiu, C. S. Herrington, and R. H. Young, Eds., pp. 172-198, IARC, Lyon, France, 4th edition, 2014
17. X. Catteau, P. Simon, and J.-C. Nöel. Detection of high-grade lesions on cell blocks from residual fluids of pap smears diagnosed as low-grade abnormalities: a preliminary pilot study. Acta Cytologica, vol. 56, no. 3, pp. 247-250, 2012
18. C. Clavel, M. Masure, J.-P. Bory et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. British Journal of Cancer, vol. 89, no. 12, pp. 1616-1623, 2001
19. A. Szarewski, D. Mesher, L. Cadman et al. Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the predictors 2 study. Journal of Clinical Microbiology, vol. 50, no. 6, pp. 1867-1873, 2012
20. J. Cuzick, L. Cadman, D. Mesher et al. Comparing the performance of six human papillomavirus tests in a screening population. British Journal of Cancer, vol. 108, no. 4, pp. 908-913, 2013
21. J. Dillner, M. Rebolj, P. Birembaut et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. British Medical Journal, vol. 377, Article ID a1754, 2008